Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Bill 2608
115th Congress(2017-2018)
Reducing Opioid Risk Act
Introduced
Introduced
Introduced in Senate on Mar 22, 2018
Overview
Text
Introduced in Senate 
Mar 22, 2018
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Mar 22, 2018)
Mar 22, 2018
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. 2608 (Introduced-in-Senate)


115th CONGRESS
2d Session
S. 2608


To provide that a risk evaluation and mitigation strategy communication plan may include information about Federal and State prescribing requirements for controlled substances.

IN THE SENATE OF THE UNITED STATES

March 22, 2018

Ms. Warren (for herself and Mrs. Capito) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To provide that a risk evaluation and mitigation strategy communication plan may include information about Federal and State prescribing requirements for controlled substances.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Reducing Opioid Risk Act”.

SEC. 2. Risk evaluation and mitigation strategy communication plans.

Section 505–1(e)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355–1(e)(3)) is amended—

(1) in subparagraph (B), by adding a semicolon at the end;

(2) in subparagraph (C), by striking “; or” and inserting a semicolon;

(3) in subparagraph (D), by striking the period and inserting “; or”; and

(4) by adding at the end the following:

    “(E) disseminating information to health care providers about Federal and State prescribing requirements for controlled substances, including the requirements under section 309(f) of the Controlled Substances Act, as applicable.”.